Company intelligence / Profile preview

Stratedigm

San Jose, California, United States

Ownership: Private
Development stage: Other

Overview

Stratedigm is an innovator in laboratory flow cytometry instrumentation, offering advanced benchtop cytometers and integrated automation systems. Their products are used worldwide in research, pre-clinical, core, and drug discovery labs for high-throughput, high-content, and multiparametric flow cytometry. The company is not a clinical-stage therapeutics developer; thus, there are no clinical program results.

Industry: Pathology

Partnerships

Certified Genetool, Inc.LK Bioscience (distributor in South Korea)

Beyond the preview

Go deeper on Stratedigm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stratedigm.

Explore the full profile